SG10201911680SA - Systems and methods for generating, visualizing and classifying molecular functional profiles - Google Patents

Systems and methods for generating, visualizing and classifying molecular functional profiles

Info

Publication number
SG10201911680SA
SG10201911680SA SG10201911680SA SG10201911680SA SG10201911680SA SG 10201911680S A SG10201911680S A SG 10201911680SA SG 10201911680S A SG10201911680S A SG 10201911680SA SG 10201911680S A SG10201911680S A SG 10201911680SA SG 10201911680S A SG10201911680S A SG 10201911680SA
Authority
SG
Singapore
Prior art keywords
visualizing
generating
systems
methods
molecular functional
Prior art date
Application number
SG10201911680SA
Other languages
English (en)
Inventor
Alexander Bagaev
Feliks Frenkel
Nikita Kotlov
Ravshan Ataullakhanov
Original Assignee
Bostongene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bostongene Corp filed Critical Bostongene Corp
Publication of SG10201911680SA publication Critical patent/SG10201911680SA/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
    • G06F16/20—Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
    • G06F16/28—Databases characterised by their database models, e.g. relational or object models
    • G06F16/284—Relational databases
    • G06F16/285—Clustering or classification
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations
    • G06F17/18—Complex mathematical operations for evaluating statistical data, e.g. average values, frequency distributions, probability functions, regression analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/20—Probabilistic models
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Public Health (AREA)
  • Databases & Information Systems (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioethics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Software Systems (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Probability & Statistics with Applications (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Mathematical Physics (AREA)
  • Computational Mathematics (AREA)
SG10201911680SA 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles SG10201911680SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762518787P 2017-06-13 2017-06-13
US201762598440P 2017-12-13 2017-12-13

Publications (1)

Publication Number Publication Date
SG10201911680SA true SG10201911680SA (en) 2020-02-27

Family

ID=62779138

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201911680SA SG10201911680SA (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
SG10201911541YA SG10201911541YA (en) 2017-06-13 2018-06-12 Systems and methods for identifying cancer treatments from normalized biomarker scores

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201911541YA SG10201911541YA (en) 2017-06-13 2018-06-12 Systems and methods for identifying cancer treatments from normalized biomarker scores

Country Status (12)

Country Link
US (28) US10340031B2 (enExample)
EP (5) EP3639170B1 (enExample)
JP (8) JP6776464B2 (enExample)
KR (1) KR102396784B1 (enExample)
CN (2) CN111033631B (enExample)
AU (4) AU2018282865B2 (enExample)
CA (1) CA3066004A1 (enExample)
DE (1) DE112018002990T5 (enExample)
GB (5) GB202209539D0 (enExample)
IL (3) IL270888B2 (enExample)
SG (2) SG10201911680SA (enExample)
WO (3) WO2018231762A1 (enExample)

Families Citing this family (141)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4414990A3 (en) 2013-01-17 2024-11-06 Personalis, Inc. Methods and systems for genetic analysis
US10125399B2 (en) 2014-10-30 2018-11-13 Personalis, Inc. Methods for using mosaicism in nucleic acids sampled distal to their origin
US11049238B2 (en) * 2015-06-22 2021-06-29 Sunnybrook Research Institute Systems and methods for prediction of tumor response to chemotherapy using pre-treatment quantitative ultrasound parameters
US11497476B2 (en) * 2015-06-22 2022-11-15 Sunnybrook Research Institute Systems and methods for prediction of tumor treatment response to using texture derivatives computed from quantitative ultrasound parameters
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
US10955504B2 (en) 2016-11-22 2021-03-23 Hyperfine Research, Inc. Systems and methods for automated detection in magnetic resonance images
US10627464B2 (en) 2016-11-22 2020-04-21 Hyperfine Research, Inc. Low-field magnetic resonance imaging methods and apparatus
GB202209539D0 (en) 2017-06-13 2022-08-10 Bostongene Corp Systems and methods for identifying cancer treatments from normalized biomarker scores
US11505831B2 (en) * 2017-12-20 2022-11-22 Dana-Farber Cancer Institute, Inc. Compositions and methods comprising digital signatures to predict response and resistance to targeted therapy and immunotherapy
US11335464B2 (en) * 2018-01-12 2022-05-17 Siemens Medical Solutions Usa, Inc. Integrated precision medicine by combining quantitative imaging techniques with quantitative genomics for improved decision making
EP3775258A4 (en) 2018-03-28 2022-01-26 Board of Regents, The University of Texas System IDENTIFICATION OF EPIGENETIC ALTERATIONS IN DNA ISOLATED FROM EXOSOMES
TW202322828A (zh) * 2018-04-12 2023-06-16 美商凱特製藥公司 利用腫瘤微環境之特性之嵌合受體ｔ細胞治療
JP7455757B2 (ja) 2018-04-13 2024-03-26 フリーノーム・ホールディングス・インコーポレイテッド 生体試料の多検体アッセイのための機械学習実装
US11475995B2 (en) 2018-05-07 2022-10-18 Perthera, Inc. Integration of multi-omic data into a single scoring model for input into a treatment recommendation ranking
US11741365B2 (en) 2018-05-14 2023-08-29 Tempus Labs, Inc. Generalizable and interpretable deep learning framework for predicting MSI from histopathology slide images
US11348661B2 (en) 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
US11348240B2 (en) 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
US10957041B2 (en) 2018-05-14 2021-03-23 Tempus Labs, Inc. Determining biomarkers from histopathology slide images
US11348239B2 (en) 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
US11574718B2 (en) * 2018-05-31 2023-02-07 Perthera, Inc. Outcome driven persona-typing for precision oncology
USD887431S1 (en) * 2018-06-18 2020-06-16 Genomic Prediction, Inc. Display screen with graphical user interface
US10395772B1 (en) * 2018-10-17 2019-08-27 Tempus Labs Mobile supplementation, extraction, and analysis of health records
USD896241S1 (en) * 2018-12-03 2020-09-15 Illumina, Inc. Display screen or portion thereof with graphical user interface
CN109712716B (zh) * 2018-12-25 2021-08-31 广州医科大学附属第一医院 疾病影响因素确定方法、系统和计算机设备
WO2020142563A1 (en) * 2018-12-31 2020-07-09 Tempus Labs, Inc. Transcriptome deconvolution of metastatic tissue samples
USD910706S1 (en) 2019-01-31 2021-02-16 Driv Ip, Llc Display screen with graphical user interface
WO2020172591A1 (en) * 2019-02-22 2020-08-27 Mitra Rxdx, Inc. A method to predict a patient's response to an anti-cancer drug from an expression level of a set of genes
ES3043308T3 (en) 2019-02-26 2025-11-25 Tempus Ai Inc Systems and methods for using sequencing data for pathogen detection
CN111621564B (zh) * 2019-02-28 2022-03-25 武汉大学 一种鉴定有效肿瘤新抗原的方法
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
US20220262462A1 (en) * 2019-04-10 2022-08-18 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Computational filtering of methylated sequence data for predictive modeling
WO2020231937A1 (en) * 2019-05-10 2020-11-19 University Of Massachusetts Irf2 as a prognostic biomarker and target for augmenting immunotherapy
JP7747524B2 (ja) * 2019-05-14 2025-10-01 テンパス エーアイ，インコーポレイテッド マルチラベルがん分類のためのシステムおよび方法
USD892825S1 (en) 2019-06-10 2020-08-11 Bostongene Corporation Display screen or portion thereof with graphical user interface
USD891445S1 (en) 2019-06-10 2020-07-28 Bostongene Corporation Display screen or portion thereof with graphical user interface
WO2020249704A1 (en) * 2019-06-13 2020-12-17 F. Hoffmann-La Roche Ag Systems and methods with improved user interface for interpreting and visualizing longitudinal data
CN110309382B (zh) * 2019-06-17 2021-05-28 暨南大学 基于多维特征的移动应用同源性边聚类方法
WO2021003246A1 (en) * 2019-07-01 2021-01-07 Accure Health Inc. Predictive liquid markers for cancer immunotherapy
US12205675B2 (en) 2019-07-03 2025-01-21 Bostongene Corporation Techniques for bias correction in sequence data
CA3147100A1 (en) * 2019-07-12 2021-01-21 Tempus Labs Adaptive order fulfillment and tracking methods and systems
US10581851B1 (en) * 2019-07-17 2020-03-03 Capital One Services, Llc Change monitoring and detection for a cloud computing environment
US11379757B2 (en) * 2019-07-31 2022-07-05 BioSymetrics, Inc. Methods, systems, and frameworks for data analytics using machine learning
CN110277135B (zh) * 2019-08-10 2021-06-01 杭州新范式生物医药科技有限公司 一种基于预期疗效选择个体化肿瘤新抗原的方法和系统
WO2021030193A1 (en) * 2019-08-13 2021-02-18 Nantomics, Llc System and method for classifying genomic data
AU2020334901A1 (en) 2019-08-16 2022-03-24 Tempus Ai, Inc. Systems and methods for detecting cellular pathway dysregulation in cancer specimens
CN110716171A (zh) * 2019-08-28 2020-01-21 上海无线电设备研究所 一种基于遗传算法的极化doa联合估计方法
EP3799057A1 (en) * 2019-09-25 2021-03-31 Koninklijke Philips N.V. Prediction tool for patient immune response to a therapy
EP4034098A4 (en) * 2019-09-27 2024-02-28 The Regents of the University of Colorado, a body corporate Enhancing cancer therapy treatment with bh3 mimetics
US20240369538A1 (en) * 2019-10-16 2024-11-07 Rene Anand Live Virus Vaccine Injury Risk
JP7470787B2 (ja) 2019-11-05 2024-04-18 パーソナリス，インコーポレイティド 単一試料からの腫瘍純度の推定
US20220396839A1 (en) * 2019-11-12 2022-12-15 Foundation Medicine, Inc. Methods of detecting a fusion gene encoding a neoantigen
CN110938627B (zh) * 2019-11-25 2021-07-06 西安交通大学第二附属医院 Esco2抑制剂在制备用于治疗下咽癌的药物中的用途
TWI709904B (zh) * 2019-11-26 2020-11-11 國立中央大學 訓練類神經網路以預測個體基因表現特徵的方法及系統
IL293374A (en) 2019-12-05 2022-07-01 Bostongene Corp Machine learning techniques for gene expression analysis
CN112574309B (zh) * 2019-12-05 2023-06-16 启愈生物技术(上海)有限公司 一种抗pd-l1纳米抗体及其用途
CA3163492A1 (en) * 2019-12-12 2021-06-17 Tempus Labs, Inc. Real-world evidence of diagnostic testing and treatment patterns in u.s. breast cancer patients
JP7617574B2 (ja) * 2020-01-07 2025-01-20 コリア アドバンスド インスティテュート オブ サイエンス アンド テクノロジー 新生抗原をスクリーニングする方法、システム及びその用途
WO2021158966A1 (en) * 2020-02-05 2021-08-12 Board Of Regents, The University Of Texas System Diagnostic and prognostic utility of exosomes in immunotherapy
JP7757291B2 (ja) * 2020-02-06 2025-10-21 オンコホスト リミテッド 治療法応答の機械学習予測
CN111292542B (zh) * 2020-02-24 2021-08-31 深圳市综合交通设计研究院有限公司 信号灯系统及其控制方法
WO2021178744A1 (en) * 2020-03-06 2021-09-10 Sanford Health Predictive test for whether a patient will benefit from pharmacogenomics testing
CN111354420B (zh) * 2020-03-08 2020-12-22 吉林大学 一种用于COVID-19病毒药物治疗的siRNA研发方法
US20210363592A1 (en) * 2020-03-11 2021-11-25 Vanderbilt University Detection of Signatures in a Breast Cancer Subject
CN115485559A (zh) 2020-03-19 2022-12-16 中外制药株式会社 预测对检查点抑制剂的反应的生物标志物
WO2021205274A1 (en) * 2020-04-08 2021-10-14 Immunitybio, Inc. Methods for assessing chemokine activity
JP2023524048A (ja) * 2020-04-29 2023-06-08 パーソナリス，インコーポレイティド 癌の免疫療法のための複合バイオマーカー
CA3177323A1 (en) * 2020-04-30 2021-11-04 Caris Mpi, Inc. Immunotherapy response signature
TWI894280B (zh) * 2020-05-26 2025-08-21 南韓商愛思阿爾法數字醫療科技有限公司 用以治療癌症惡病質之系統、用以治療癌症惡病質之運算系統及其操作方法、以及非暫態電腦可讀取媒體
CN111863137B (zh) * 2020-05-28 2024-01-02 上海朴岱生物科技合伙企业（有限合伙） 一种基于高通量测序数据和临床表型构建复杂疾病状态评估方法及应用
CN111755073B (zh) * 2020-05-31 2022-11-15 复旦大学 基于转录组的pd-1疗法治疗效果预测系统
JP7570088B2 (ja) * 2020-06-18 2024-10-21 国立研究開発法人産業技術総合研究所 情報処理システム、情報処理方法、同定方法及びプログラム
JP2023532888A (ja) 2020-06-27 2023-08-01 クレセンタ バイオサイエンシズ 細胞代謝を調節する化合物の組成及び使用方法
CN111863120B (zh) * 2020-06-28 2022-05-13 深圳晶泰科技有限公司 晶体复合物的药物虚拟筛选系统及方法
WO2022010866A1 (en) 2020-07-06 2022-01-13 Bostongene Corporation Tumor microenvironment-based methods for assessing car-t and other immunotherapies
CA3125419A1 (en) * 2020-07-23 2022-01-23 The DNA Company Inc. Systems and methods for determining a physiological profile using genetic information
WO2022016447A1 (zh) * 2020-07-23 2022-01-27 碳逻辑生物科技(香港)有限公司 用于评估结直肠癌患者对免疫治疗药物响应性的标志物
WO2022031620A2 (en) * 2020-08-01 2022-02-10 Aigene Methods for the rapid assessment of the efficacy of cancer therapy and related applications
CN112147326B (zh) * 2020-09-04 2022-04-08 北京大学 一种肿瘤免疫细胞亚群分型精准检测试剂盒
CN112086199B (zh) * 2020-09-14 2023-06-09 中科院计算所西部高等技术研究院 基于多组学数据的肝癌数据处理系统
WO2022059026A1 (en) * 2020-09-21 2022-03-24 Mestastop Solutions Private Limited Systems and methods for predicting cancer metastasis and screening of drugs
WO2022089426A1 (zh) * 2020-10-27 2022-05-05 细胞图谱有限公司 外周血样本分析方法和试剂盒
WO2022109607A2 (en) * 2020-11-19 2022-05-27 Tempus Labs, Inc. Determination of cytotoxic gene signature and associated systems and methods for response prediction and treatment
CN112637134A (zh) * 2020-12-02 2021-04-09 电子科技大学 一种用于数据链通信系统跳时信号的信号分选方法
CN112530581B (zh) * 2020-12-03 2023-11-21 安徽医科大学第一附属医院 一种前列腺癌患者的免疫分子分类系统及其应用
EP4394048A3 (en) 2020-12-11 2024-09-25 BostonGene Corporation Techniques for identifying follicular lymphoma types
TWD216917S (zh) 2020-12-11 2022-02-01 股感媒體科技股份有限公司 顯示面板之圖形化使用者介面
US12161635B2 (en) 2020-12-22 2024-12-10 Case Western Reserve University Compositions and methods of treating PIK3CA helical domain mutant cancers
CN112635063B (zh) * 2020-12-30 2022-05-24 华南理工大学 一种肺癌预后综合预测模型、构建方法及装置
WO2022159569A1 (en) * 2021-01-20 2022-07-28 Memorial Sloan Kettering Cancer Center Peripheral blood phenotype linked to outcomes after immunotherapy treatment
JP7697790B2 (ja) * 2021-01-21 2025-06-24 キヤノンメディカルシステムズ株式会社 医療情報処理装置
CN112735520B (zh) * 2021-02-03 2021-07-20 深圳裕康医学检验实验室 肿瘤个体化免疫治疗基因检测结果的解读方法、系统和存储介质
EP4305427A4 (en) * 2021-03-08 2025-07-23 Venn Biosciences Corp BIOMARKERS TO DETERMINE AN IMMUNO-ONOCOLOGICAL RESPONSE
CN112863595A (zh) * 2021-03-08 2021-05-28 中国农业科学院兰州畜牧与兽药研究所 一种基于MeRIP-Seq技术挖掘藏绵羊高原低氧适应性相关基因的方法
WO2022192457A1 (en) 2021-03-09 2022-09-15 Bostongene Corporation Predicting response to treatments in patients with clear cell renal cell carcinoma
WO2022192393A1 (en) 2021-03-09 2022-09-15 Bostongene Corporation B cell-enriched tumor microenvironments
EP4305210A1 (en) * 2021-03-09 2024-01-17 BostonGene Corporation Gastric cancer tumor microenvironments
EP4305191A4 (en) * 2021-03-12 2025-02-26 Pragma Biosciences Inc. Systems and methods for identifying microbial biosynthetic genetic clusters
CN112698044B (zh) * 2021-03-23 2021-06-22 信纳克(北京)生化标志物检测医学研究有限责任公司 靶向治疗后免疫状态评价装置及方法
ES1277194Y (es) * 2021-03-25 2021-11-26 Keyzell Holding Sl Sistema basado en inteligencia artificial para analizar biomarcadores y personalizar tratamientos para cáncer
US11931127B1 (en) 2021-04-08 2024-03-19 T-Mobile Usa, Inc. Monitoring users biological indicators using a 5G telecommunication network
WO2022221853A1 (en) 2021-04-13 2022-10-20 Elegen Corp. Methods and compositions for cell-free cloning
AU2022275923A1 (en) * 2021-05-18 2023-11-23 Bostongene Corporation Techniques for single sample expression projection to an expression cohort sequenced with another protocol
USD1027977S1 (en) 2021-06-28 2024-05-21 Gestalt Diagnostics, LLC Display screen or portion thereof having a graphical user interface
WO2023017525A1 (en) * 2021-08-11 2023-02-16 OncoHost Ltd. Predicting patient response
US20260071275A1 (en) * 2021-09-30 2026-03-12 Selonterra, Inc. Use of c9orf72 -mediated genes for diagnosis and treatment of neuronal diseases
WO2023059654A1 (en) 2021-10-05 2023-04-13 Personalis, Inc. Customized assays for personalized cancer monitoring
EP4423301B1 (en) 2021-10-29 2025-12-10 BostonGene Corporation Tumor microenvironment types in breast cancer
EP4436671A2 (en) * 2021-11-22 2024-10-02 Venn Biosciences Corporation Predicting sarcoma treatment response using targeted quantification of site-specific protein glycosylation
US20250006317A1 (en) * 2021-11-23 2025-01-02 Curematch, Inc. Clinical trial optimization
USD1005310S1 (en) * 2021-12-02 2023-11-21 Inspire Medical Systems, Inc. Display screen or portion thereof with a graphical user interface
US12051490B2 (en) 2021-12-03 2024-07-30 Digital Diagnostics Inc. Direct medical treatment predictions using artificial intelligence
JP2023091970A (ja) * 2021-12-21 2023-07-03 行正 塩津 提示装置及びプログラム
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds
JP7826013B2 (ja) * 2022-01-13 2026-03-09 キヤノンメディカルシステムズ株式会社 医用情報処理装置、方法およびプログラム
CN118786226A (zh) * 2022-01-13 2024-10-15 新索思股份有限公司 用于选择受试者和用il-2疗法治疗癌症的方法
US20230290440A1 (en) 2022-02-14 2023-09-14 Bostongene Corporation Urothelial tumor microenvironment (tme) types
WO2023168049A2 (en) * 2022-03-04 2023-09-07 Bostongene Corporation Cytokine gene expression signatures
WO2023194090A1 (en) 2022-04-08 2023-10-12 Bayer Aktiengesellschaft Multiple instance learning considering neighborhood aggregations
US20250265832A1 (en) 2022-04-26 2025-08-21 Bayer Aktiengesellschaft Multiple-instance learning based on regional embeddings
WO2023213623A1 (en) 2022-05-03 2023-11-09 Bayer Aktiengesellschaft Dynamic sampling strategy for multiple-instance learning
USD1027999S1 (en) * 2022-05-13 2024-05-21 Inspire Medical Systems, Inc. Display screen or portion thereof with an animated graphical user interface
US20260112450A1 (en) * 2022-07-26 2026-04-23 Washington University Methods for selection of cancer patients for anti-angiogenic and immune checkpoint blockage therapies and combinations thereof
JP2025529765A (ja) * 2022-08-11 2025-09-09 オンコホスト リミテッド 患者の応答の予測
WO2024054951A1 (en) * 2022-09-08 2024-03-14 Cardiff Oncology, Inc. Methods of monitoring mutations in treatment of colorectal cancer
CN115312153B (zh) * 2022-09-15 2025-09-26 重庆邮电大学 基于多阶段高斯伪谱法的癌症化疗智能监测与优化给药系统
WO2024081737A1 (en) * 2022-10-12 2024-04-18 Exagen Inc. Biomarker selection for machine learning enabled prediction of treatment response
US20240177803A1 (en) 2022-11-17 2024-05-30 Bostongene Corporation Comprehensive immunoprofiling of peripheral blood
USD1042503S1 (en) * 2022-12-05 2024-09-17 Igt Display screen or a portion thereof with a graphical user interface
USD1050174S1 (en) 2022-12-05 2024-11-05 Igt Display screen or a portion thereof with a graphical user interface
WO2024151840A1 (en) 2023-01-13 2024-07-18 Bostongene Corporation Tumor microenvironment types in lung adenocarcinoma
EP4695425A1 (en) * 2023-04-13 2026-02-18 BostonGene Corporation Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltration
WO2024220680A2 (en) * 2023-04-20 2024-10-24 Foundation Medicine, Inc. Methods and systems for predicting treatment response to mono-immunotherapy and chemo-immunotherapy
CN116721699B (zh) * 2023-04-27 2024-10-18 百洋智能科技集团股份有限公司 一种基于肿瘤基因检测结果的智能推荐方法
CN116248680B (zh) * 2023-05-11 2023-08-01 湖南工商大学 一种从头肽段测序方法、装置及相关设备
WO2024242714A1 (en) * 2023-05-22 2024-11-28 Venn Biosciences Corporation Methods and systems for analyzing site-specific monomer composition
USD1118634S1 (en) * 2023-10-11 2026-03-17 Open Text Inc. Display screen or portion thereof with graphical user interface for visualizing connections between base entities of a story corresponding to a security issue
CN117095743B (zh) * 2023-10-17 2024-01-05 山东鲁润阿胶药业有限公司 一种小分子肽阿胶的多肽谱匹配数据分析方法及系统
US20260120879A1 (en) 2023-10-31 2026-04-30 Bostongene Corporation Machine learning technique for identifying ici responders and non-responders
WO2025094183A1 (en) * 2023-10-31 2025-05-08 OncoHost Ltd. Predicting anti-cancer therapy related adverse event
CN117542529B (zh) * 2024-01-10 2024-04-02 北京博富瑞基因诊断技术有限公司 Hla不相合异基因造血干细胞移植非复发死亡风险的预测方法、系统、设备、存储介质
CN117877721B (zh) * 2024-03-12 2025-03-07 天津市肿瘤医院（天津医科大学肿瘤医院） 一种个性化甲状腺癌放疗后内分泌治疗管理系统

Family Cites Families (177)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US280468A (en) * 1883-07-03 Carrier for store-service apparatus
US4777127A (en) 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
GB8702816D0 (en) 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
US5422120A (en) 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
AP129A (en) 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
WO1990007936A1 (en) 1989-01-23 1990-07-26 Chiron Corporation Recombinant therapies for infection and hyperproliferative disorders
CA2489769A1 (en) 1989-03-21 1990-10-04 Philip L. Felgner Expression of exogenous polynucleotide sequences in a vertebrate
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
AU648261B2 (en) 1989-08-18 1994-04-21 Novartis Vaccines And Diagnostics, Inc. Recombinant retroviruses delivering vector constructs to target cells
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
ZA911974B (en) 1990-03-21 1994-08-22 Res Dev Foundation Heterovesicular liposomes
DE69233013T2 (de) 1991-08-20 2004-03-04 The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
WO1993010218A1 (en) 1991-11-14 1993-05-27 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Vectors including foreign genes and negative selective markers
GB9125623D0 (en) 1991-12-02 1992-01-29 Dynal As Cell modification
FR2688514A1 (fr) 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
EP0650370A4 (en) 1992-06-08 1995-11-22 Univ California METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
CA2137361A1 (en) 1992-06-10 1993-12-23 W. French Anderson Vector particles resistant to inactivation by human serum
GB2269175A (en) 1992-07-31 1994-02-02 Imperial College Retroviral vectors
EP1024198A3 (en) 1992-12-03 2002-05-29 Genzyme Corporation Pseudo-adenoviral vectors for the gene therapy of haemophiliae
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
PT695169E (pt) 1993-04-22 2003-04-30 Skyepharma Inc Lipossomas multivesiculares de ciclodextrina encapsulando compostos farmacologicos e metodos para a sua utilizacao
EP0705344B8 (en) 1993-06-24 2006-05-10 Advec Inc. Adenovirus vectors for gene therapy
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
DK0814154T3 (da) 1993-09-15 2009-08-31 Novartis Vaccines & Diagnostic Rekombinante alfavirusvektorer
AU687117B2 (en) 1993-10-25 1998-02-19 Canji, Inc. Recombinant adenoviral vector and methods of use
AU686277B2 (en) 1993-11-16 1998-02-05 Pacira Pharmaceuticals, Inc. Vesicles with controlled release of actives
DE69535669T2 (de) 1994-05-09 2008-12-04 Oxford Biomedica (Uk) Ltd. Retrovirale vektoren mit verminderter rekombinationsrate
AU4594996A (en) 1994-11-30 1996-06-19 Chiron Viagene, Inc. Recombinant alphavirus vectors
WO1997042338A1 (en) 1996-05-06 1997-11-13 Chiron Corporation Crossless retroviral vectors
WO2000053211A2 (en) 1999-03-09 2000-09-14 University Of Southern California Method of promoting myocyte proliferation and myocardial tissue repair
US7905134B2 (en) 2002-08-06 2011-03-15 The Regents Of The University Of California Biomarker normalization
US20040191819A1 (en) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corporation Expression profiles for breast cancer and methods of use
USD496297S1 (en) * 2003-11-13 2004-09-21 Susan M. Kahil Face for a timepiece
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
US7862995B2 (en) 2004-12-10 2011-01-04 Targeted Molecular Diagnostics Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
WO2006133460A2 (en) * 2005-06-09 2006-12-14 Yale University Methods for diagnosing and treating breast cancer based on a her/er ratio
CA2624086A1 (en) * 2005-09-28 2007-04-05 H. Lee Moffitt Cancer Center Individualized cancer treatments
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
NZ544432A (en) * 2005-12-23 2009-07-31 Pacific Edge Biotechnology Ltd Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS
US8068994B2 (en) 2007-07-27 2011-11-29 Wayne State University Method for analyzing biological networks
NZ562237A (en) 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
US20090105167A1 (en) 2007-10-19 2009-04-23 Duke University Predicting responsiveness to cancer therapeutics
WO2009146545A1 (en) 2008-06-05 2009-12-10 University Health Network Compositions and methods for classifying lung cancer and prognosing lung cancer survival
CN102040569B (zh) 2009-10-20 2012-11-07 北京绿色金可生物技术股份有限公司 类胡萝卜素衍生物及其制备方法和应用
WO2011068839A1 (en) * 2009-12-01 2011-06-09 Compendia Bioscience, Inc. Classification of cancers
US20120237488A1 (en) * 2009-12-04 2012-09-20 University Health Network Lsc and hsc signatures for predicting survival of patients having hematological cancer
US20110171323A1 (en) * 2010-01-09 2011-07-14 The Translational Genomics Research Institute Methods and kits to predict prognostic and therapeutic outcome in small cell lung cancer
USD697080S1 (en) * 2010-02-26 2014-01-07 Draeger Medical Systems, Inc. Display screen with an icon
US9400958B2 (en) * 2010-06-30 2016-07-26 Oracle International Corporation Techniques for display of information related to policies
PL2619576T3 (pl) * 2010-09-24 2021-07-05 Niels Grabe Środki i sposoby do prognozowania odpowiedzi na leczenie u pacjenta chorego na nowotwór złośliwy
US20140018255A1 (en) 2011-01-11 2014-01-16 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for predicting the outcome of a cancer in a patient by analysing gene expression
WO2012122347A1 (en) * 2011-03-10 2012-09-13 Teva Pharmaceutical Industries Ltd. A method, system and program for improved health care
US10260097B2 (en) * 2011-06-02 2019-04-16 Almac Diagnostics Limited Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent
WO2012170513A2 (en) 2011-06-06 2012-12-13 Women & Infants' Hospital Of Rhode Island He4 based therapy for malignant disease
US20140222443A1 (en) * 2011-06-07 2014-08-07 Kathleen Danenberg Molecular profiling for cancer
WO2012170710A1 (en) * 2011-06-08 2012-12-13 Altheadx Incorporated Disease classification modules
JP2014519340A (ja) * 2011-06-16 2014-08-14 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． バイオマーカー組成物および方法
WO2013030841A1 (en) * 2011-09-04 2013-03-07 Yissum Research Development Company Of The Hebrew Universitiy Of Jerusalem Ltd. Prognostic methods and compositions for predicting interferon treatment eficacy in a subject
JP2015503330A (ja) 2011-12-22 2015-02-02 アベオ ファーマシューティカルズ， インコーポレイテッド 多重遺伝子バイオマーカーの同定
US20140363816A1 (en) * 2011-12-22 2014-12-11 The Regents Of The University Of Colorado, A Body Corporate Methods for prediction of clinical response to radiation therapy in cancer patients
EP2885640B1 (en) * 2012-08-16 2018-07-18 Genomedx Biosciences, Inc. Prostate cancer prognostics using biomarkers
USD743413S1 (en) * 2012-09-19 2015-11-17 ABBYY InfoPiosk LLC Display screen or portion thereof with graphical user interface
SG11201504023SA (en) * 2012-12-03 2015-06-29 Almac Diagnostics Ltd Molecular diagnostic test for cancer
USD719177S1 (en) * 2012-12-27 2014-12-09 Jason M. Cohen Display screen or portion thereof with graphical user interface
MX2015009780A (es) * 2013-01-29 2016-04-04 Molecular Health Gmbh Sistemas y metodos para soporte de decision clinica.
US9809857B2 (en) * 2013-02-28 2017-11-07 Washington University Methods and signatures for oropharyngeal cancer prognosis
USD735732S1 (en) * 2013-03-12 2015-08-04 Hewlett-Packard Development Company, L.P. Display screen with graphical user interface
BR112015023120A2 (pt) * 2013-03-15 2017-11-21 Genentech Inc método para identificar um indivíduo com uma doença ou disfunção, método para prever a responsividade de um indivíduo com uma doença ou disfunção, método para determinar a probabilidade de que um indivíduo com uma doença ou disfunção exibirá benefício do tratamento, método para selecionar uma terapia, usos de um antagonista de ligação do eixo pd-l1, ensaio para identificar um indivíduo com uma doença, kit de diagnóstico, método para avaliar uma resposta ao tratamento e método para monitorar a resposta de um indivíduo tratado
EP2787670A1 (en) 2013-04-05 2014-10-08 Panasonic Intellectual Property Corporation of America MCS table adaptation for 256-QAM
USD725148S1 (en) * 2013-04-30 2015-03-24 Microsoft Corporation Display screen with animated icon
US10679730B2 (en) * 2013-05-28 2020-06-09 The University Of Chicago Prognostic and predictive breast cancer signature
USD741912S1 (en) * 2013-05-29 2015-10-27 Microsoft Corporation Display screen with animated graphical user interface
USD743423S1 (en) * 2013-06-04 2015-11-17 Abbyy Infopoisk Llc Display screen or portion thereof with graphical user interface
USD805535S1 (en) * 2013-06-04 2017-12-19 Abbyy Production Llc Display screen or portion thereof with a transitional graphical user interface
USD743424S1 (en) * 2013-06-04 2015-11-17 Abbyy Infopoisk Llc Display screen or portion thereof with graphical user interface
USD755240S1 (en) * 2013-06-09 2016-05-03 Apple Inc. Display screen or portion thereof with graphical user interface
USD819649S1 (en) * 2013-06-09 2018-06-05 Apple Inc. Display screen or portion thereof with graphical user interface
AU2014284124B2 (en) 2013-06-20 2020-03-12 Immunexpress Pty Ltd Biomarker identification
USD744500S1 (en) * 2013-07-05 2015-12-01 Lg Electronics Inc. Display screen with transitional graphical user interface
US20160154928A1 (en) * 2013-07-12 2016-06-02 Immuneering Corporation Systems, methods, and environment for automated review of genomic data to identify downregulated and/or upregulated gene expression indicative of a disease or condition
USD708193S1 (en) * 2013-08-30 2014-07-01 Nike, Inc. Display screen with graphical user interface
USD746831S1 (en) * 2013-09-10 2016-01-05 Apple Inc. Display screen or portion thereof with graphical user interface
USD759068S1 (en) * 2013-09-23 2016-06-14 Bally Gaming, Inc. Display screen or portion thereof with a baccarat game graphical user interface
US20150147339A1 (en) 2013-11-15 2015-05-28 Psma Development Company, Llc Biomarkers for psma targeted therapy for prostate cancer
US20150205509A1 (en) * 2013-12-02 2015-07-23 Daydials, Inc. User interface using graphical dials to represent user activity
EP3090066A4 (en) * 2014-01-02 2017-08-30 Memorial Sloan Kettering Cancer Center Determinants of cancer response to immunotherapy
JP2017512304A (ja) * 2014-02-06 2017-05-18 イミューンエクスプレス・プロプライエタリー・リミテッドＩｍｍｕｎｅＸｐｒｅｓｓ Ｐｔｙ Ｌｔｄ バイオマーカーシグネチャー法ならびにそのための装置およびキット
GB201409479D0 (en) * 2014-05-28 2014-07-09 Almac Diagnostics Ltd Molecular diagnostic test for cancer
USD771063S1 (en) * 2014-02-21 2016-11-08 Huawei Device Co., Ltd. Display screen or portion thereof with animated graphical user interface
US20150254433A1 (en) * 2014-03-05 2015-09-10 Bruce MACHER Methods and Models for Determining Likelihood of Cancer Drug Treatment Success Utilizing Predictor Biomarkers, and Methods of Diagnosing and Treating Cancer Using the Biomarkers
BR112016020897A2 (en) * 2014-03-11 2018-01-23 The Council Of The Queensland Institute Of Medical Research Determination of cancer aggressiveness, prognosis, and responsiveness to treatment
USD711420S1 (en) * 2014-03-14 2014-08-19 Nike, Inc. Display screen with graphical user interface for athletic achievements
USD772241S1 (en) * 2014-03-19 2016-11-22 Symantec Corporation Display screen or portion thereof with transitional graphical user interface
USD759076S1 (en) * 2014-04-18 2016-06-14 Nutonian, Inc. Display screen with graphical user interface
US20150317430A1 (en) * 2014-05-05 2015-11-05 Advaita Corporation Systems and methods for analyzing biological pathways for the purpose of modeling drug effects, side effects, and interactions
EP3795698B1 (en) * 2014-05-12 2023-03-01 Janssen Pharmaceutica NV Biological markers for identifying patients for treatment with abiraterone acetate
FR3021776A1 (fr) * 2014-05-28 2015-12-04 Vaiomer Procede d'identification d'une relation entre des elements physiques
WO2016015095A1 (en) 2014-07-31 2016-02-04 The University Of Western Australia A method for the identification of immunotherapy-drug combinations using a network approach
USD753696S1 (en) * 2014-09-01 2016-04-12 Apple Inc. Display screen or portion thereof with graphical user interface
USD762691S1 (en) * 2014-09-01 2016-08-02 Apple Inc. Display screen or portion thereof with graphical user interface
USD765114S1 (en) * 2014-09-02 2016-08-30 Apple Inc. Display screen or portion thereof with graphical user interface
USD757079S1 (en) * 2014-09-02 2016-05-24 Apple Inc. Display screen or portion thereof with graphical user interface
USD765693S1 (en) * 2014-09-02 2016-09-06 Apple Inc. Display screen or portion thereof with graphical user interface
USD766950S1 (en) * 2014-09-02 2016-09-20 Apple Inc. Display screen or portion thereof with graphical user interface
US11275080B2 (en) 2014-11-05 2022-03-15 The Regents Of The University Of California Methods for stratifying non-responders to therapies that block PD1/PDL1 axis
USD765673S1 (en) * 2014-12-30 2016-09-06 Energous Corporation Display screen with graphical user interface
JP2018503373A (ja) 2014-12-30 2018-02-08 ジェネンテック， インコーポレイテッド がんの予後診断及び治療のための方法及び組成物
USD784402S1 (en) * 2015-02-04 2017-04-18 Sengled Optoelectronics Co., Ltd Display screen with animated graphical user interface
USD765098S1 (en) * 2015-03-06 2016-08-30 Apple Inc. Display screen or portion thereof with graphical user interface
USD775185S1 (en) * 2015-03-06 2016-12-27 Apple Inc. Display screen or portion thereof with graphical user interface
US20190057182A1 (en) * 2015-05-22 2019-02-21 Csts Health Care Inc. Biomarker-driven molecularly targeted combination therapies based on knowledge representation pathway analysis
AU2016267392B2 (en) 2015-05-28 2021-12-09 Immunexpress Pty Ltd Validating biomarker measurement
WO2017004153A1 (en) 2015-06-29 2017-01-05 The Broad Institute Inc. Tumor and microenvironment gene expression, compositions of matter and methods of use thereof
GB201512869D0 (en) 2015-07-21 2015-09-02 Almac Diagnostics Ltd Gene signature for minute therapies
US10835604B2 (en) * 2015-08-13 2020-11-17 Northeastern University Biomaterials for combined radiotherapy and immunotherapy of cancer
WO2017059003A1 (en) * 2015-09-29 2017-04-06 Crescendo Bioscience Biomarkers and methods for assessing psoriatic arthritis disease activity
WO2017058999A2 (en) * 2015-09-29 2017-04-06 Crescendo Bioscience Biomarkers and methods for assessing response to inflammatory disease therapy withdrawal
USD809535S1 (en) * 2015-10-06 2018-02-06 Lg Electronics Inc. Vehicle dashboard display screen with an animated graphical user interface
USD855629S1 (en) * 2015-10-23 2019-08-06 Sony Corporation Display panel or screen or portion thereof with an animated graphical user interface
USD783656S1 (en) * 2015-10-28 2017-04-11 SynerScope B.V. Display screen with graphical user interface
USD795922S1 (en) * 2015-11-05 2017-08-29 Samsung Electronics Co., Ltd. Display screen or portion thereof with animated graphical user interface
USD797124S1 (en) * 2015-11-18 2017-09-12 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
GB201521481D0 (en) 2015-12-04 2016-01-20 Healx Ltd Prognostic system
USD799516S1 (en) * 2015-12-23 2017-10-10 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
USD806730S1 (en) * 2016-01-05 2018-01-02 Kneevoice, Inc. Display screen or portion thereof with graphical user interface
USD782516S1 (en) * 2016-01-19 2017-03-28 Apple Inc. Display screen or portion thereof with graphical user interface
CA169252S (en) * 2016-02-04 2018-07-24 Coway Co Ltd Display screen with animated graphical user interface
USD810757S1 (en) * 2016-02-19 2018-02-20 Samsung Electronics Co., Ltd. Display screen or portion thereof with transitional graphical user interface
JP1572940S (enExample) * 2016-03-16 2018-06-18
USD807913S1 (en) * 2016-03-17 2018-01-16 Lg Electronics Inc. Display panel with transitional graphical user interface
USD802611S1 (en) * 2016-04-14 2017-11-14 Alpha Dominche Holdings, Inc. Beverage brewer display screen with graphical user interface
EP3455631B1 (en) 2016-05-09 2020-06-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for classifying patients with a solid cancer
USD804502S1 (en) * 2016-06-11 2017-12-05 Apple Inc. Display screen or portion thereof with graphical user interface
USD835121S1 (en) * 2016-06-15 2018-12-04 Sony Interactive Entertainment Europe Limited Display screen or portion thereof with graphical user interface
USD882583S1 (en) * 2016-07-12 2020-04-28 Google Llc Display screen with graphical user interface
USD840413S1 (en) * 2016-08-15 2019-02-12 Facebook, Inc. Display screen or portion thereof with digital visual codes graphical user interface
USD852209S1 (en) * 2016-08-24 2019-06-25 Beijing Kingsoft Internet Security Software Co., Ltd. Mobile communication terminal with animated graphical user interface
USD813250S1 (en) * 2016-08-30 2018-03-20 Ponsse Oyj Display screen with graphical user interface
JP7295015B2 (ja) * 2016-10-07 2023-06-20 オムニセック インコーポレイテッド 個別化治療を決定するための方法
USD806120S1 (en) * 2016-10-31 2017-12-26 Agile Transformation, Inc. Display screen or portion thereof with icon
USD847857S1 (en) * 2016-10-31 2019-05-07 Agile Transformation, Inc. Display screen or portion thereof with icon
USD829730S1 (en) * 2016-11-10 2018-10-02 Karma Automotive Llc Display screen with an infotainment graphical user interface
USD865776S1 (en) * 2016-11-18 2019-11-05 Luis Miguel Porturas Display screen with graphical user interface
USD813249S1 (en) * 2017-02-22 2018-03-20 Banuba Limited Display screen with an animated graphical user interface
USD832283S1 (en) * 2017-03-28 2018-10-30 Akamai Technologies, Inc. Display screen with animated graphical user interface
USD822705S1 (en) * 2017-04-20 2018-07-10 Palantir Technologies, Inc. Display screen or portion thereof with graphical user interface
USD880489S1 (en) * 2017-05-18 2020-04-07 The Coca-Cola Company Beverage dispenser display screen or portion thereof with animated graphical user interface
USD818494S1 (en) * 2017-06-04 2018-05-22 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD822059S1 (en) * 2017-06-05 2018-07-03 Apple Inc. Display screen or portion thereof with graphical user interface
GB202209539D0 (en) 2017-06-13 2022-08-10 Bostongene Corp Systems and methods for identifying cancer treatments from normalized biomarker scores
USD879808S1 (en) * 2017-06-20 2020-03-31 Ethicon Llc Display panel with graphical user interface
CN111868260B (zh) 2017-08-07 2025-02-21 约翰斯霍普金斯大学 用于评估和治疗癌症的方法和材料
USD833471S1 (en) * 2017-08-18 2018-11-13 Salesforce.Com, Inc. Display screen or portion thereof with animated graphical user interface
USD846585S1 (en) * 2017-08-22 2019-04-23 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
USD840415S1 (en) * 2017-08-25 2019-02-12 Samsung Electronics Co., Ltd. Display screen or portion thereof with transitional graphical user interface
USD860228S1 (en) * 2017-09-05 2019-09-17 Byton Limited Display screen with a graphical user interface
USD868103S1 (en) * 2017-09-27 2019-11-26 Toyota Research Institute, Inc. Display screen or portion thereof with an animated graphical user interface
WO2019070755A1 (en) * 2017-10-02 2019-04-11 The Broad Institute, Inc. METHODS AND COMPOSITIONS FOR DETECTING AND MODULATING A GENETIC SIGNATURE OF IMMUNOTHERAPY RESISTANCE IN CANCER
USD861022S1 (en) * 2017-10-13 2019-09-24 Honeywell International Inc. Display screen or portion thereof with a graphical user interface
USD879112S1 (en) * 2017-11-14 2020-03-24 Geographic Services, Inc. Display screen or portion thereof with graphical user interface
USD873854S1 (en) * 2017-11-24 2020-01-28 Fujifilm Corporation Display screen or portion thereof with transitional icon
USD870763S1 (en) * 2018-01-05 2019-12-24 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
USD852820S1 (en) * 2018-01-19 2019-07-02 Mouth Player Inc. Display screen or portion thereof with animated graphical user interface
USD878393S1 (en) * 2018-01-30 2020-03-17 Magic Leap, Inc. Display panel or portion thereof with a transitional mixed reality graphical user interface
USD868812S1 (en) * 2018-02-16 2019-12-03 Early Warning Services, Llc Display screen portion with animated graphical user interface for transmittal notification
USD868811S1 (en) * 2018-02-22 2019-12-03 Samsung Electronics Co., Ltd. Display screen or portion thereof with transitional graphical user interface
USD874482S1 (en) * 2018-02-28 2020-02-04 Fujifilm Corporation Display screen or portion thereof with icon
USD865807S1 (en) * 2018-07-24 2019-11-05 Magic Leap, Inc. Display panel or portion thereof with a graphical user interface
USD877176S1 (en) * 2018-07-24 2020-03-03 Magic Leap, Inc. Display panel or portion thereof with a transitional graphical user interface
USD879147S1 (en) * 2018-07-31 2020-03-24 Google Llc Display screen with animated icon
USD868094S1 (en) * 2018-08-30 2019-11-26 Apple Inc. Electronic device with graphical user interface
USD882615S1 (en) * 2018-09-06 2020-04-28 Apple Inc. Electronic device with animated graphical user interface
USD855073S1 (en) * 2019-04-05 2019-07-30 Le-Vel Brands, Llc Display screen with icon
WO2021092071A1 (en) 2019-11-07 2021-05-14 Oncxerna Therapeutics, Inc. Classification of tumor microenvironments
EP4394048A3 (en) 2020-12-11 2024-09-25 BostonGene Corporation Techniques for identifying follicular lymphoma types
US20230290440A1 (en) 2022-02-14 2023-09-14 Bostongene Corporation Urothelial tumor microenvironment (tme) types

Also Published As

Publication number Publication date
US20180357377A1 (en) 2018-12-13
US20180358132A1 (en) 2018-12-13
US20190243943A9 (en) 2019-08-08
WO2018231762A8 (en) 2019-12-19
US20190252046A1 (en) 2019-08-15
US20200075131A1 (en) 2020-03-05
IL270887B2 (en) 2025-01-01
EP3639172B1 (en) 2021-03-31
US20180357374A1 (en) 2018-12-13
IL270887A (en) 2020-01-30
US20210257058A1 (en) 2021-08-19
US20180357361A1 (en) 2018-12-13
US20200175135A9 (en) 2020-06-04
US11302420B2 (en) 2022-04-12
US20180358125A1 (en) 2018-12-13
US20180357372A1 (en) 2018-12-13
JP2023169202A (ja) 2023-11-29
KR102396784B1 (ko) 2022-05-13
JP6776464B2 (ja) 2020-10-28
EP3639169A1 (en) 2020-04-22
US20180358128A1 (en) 2018-12-13
US11322226B2 (en) 2022-05-03
JP2020528268A (ja) 2020-09-24
JP2024029038A (ja) 2024-03-05
US10580517B2 (en) 2020-03-03
GB2576680B (en) 2022-03-23
EP3639170B1 (en) 2021-03-24
US20200175133A9 (en) 2020-06-04
GB202201288D0 (en) 2022-03-16
EP4012713A1 (en) 2022-06-15
JP6999771B2 (ja) 2022-02-04
USD890779S1 (en) 2020-07-21
US20180357376A1 (en) 2018-12-13
US20190332744A9 (en) 2019-10-31
US20200335180A1 (en) 2020-10-22
US10504615B2 (en) 2019-12-10
US11004542B2 (en) 2021-05-11
SG10201911541YA (en) 2020-02-27
US11373733B2 (en) 2022-06-28
US10706954B2 (en) 2020-07-07
EP4012713B1 (en) 2025-10-29
GB2601923A (en) 2022-06-15
US10311967B2 (en) 2019-06-04
US10636514B2 (en) 2020-04-28
EP3639169B1 (en) 2022-03-23
CN111033631A (zh) 2020-04-17
AU2018282759A2 (en) 2021-01-07
JP2020523028A (ja) 2020-08-06
IL270887B1 (en) 2024-09-01
AU2018282865B2 (en) 2024-10-10
US20200175134A9 (en) 2020-06-04
US20180357378A1 (en) 2018-12-13
CN111052247A (zh) 2020-04-21
EP3879535B1 (en) 2024-12-11
US20180357362A1 (en) 2018-12-13
IL270888A (en) 2020-01-30
CN111033631B (zh) 2024-03-12
US20200273543A1 (en) 2020-08-27
IL270888B2 (en) 2024-12-01
GB2601923B (en) 2023-01-04
JP7034183B2 (ja) 2022-03-11
JP2021036868A (ja) 2021-03-11
EP3639170A1 (en) 2020-04-22
GB2577828A (en) 2020-04-08
GB201918035D0 (en) 2020-01-22
WO2018231762A1 (en) 2018-12-20
JP2021072778A (ja) 2021-05-13
US10340030B2 (en) 2019-07-02
AU2018284077B2 (en) 2021-09-23
WO2018231771A1 (en) 2018-12-20
CN111052247B (zh) 2024-06-14
GB202209539D0 (en) 2022-08-10
GB2601923B8 (en) 2023-03-08
JP2022050445A (ja) 2022-03-30
US20240006029A1 (en) 2024-01-04
GB2576857B (en) 2022-12-07
US10340031B2 (en) 2019-07-02
US20180357373A1 (en) 2018-12-13
US10720230B2 (en) 2020-07-21
JP7408534B2 (ja) 2024-01-05
US11842797B2 (en) 2023-12-12
US20200098443A1 (en) 2020-03-26
US11984200B2 (en) 2024-05-14
US20210249107A9 (en) 2021-08-12
US10650911B2 (en) 2020-05-12
AU2018102201A4 (en) 2021-01-21
WO2018231772A1 (en) 2018-12-20
IL270888B1 (en) 2024-08-01
GB2576857A (en) 2020-03-04
EP3639172A1 (en) 2020-04-22
US10636513B2 (en) 2020-04-28
CA3066004A1 (en) 2018-12-20
EP3879535A1 (en) 2021-09-15
US20200265924A1 (en) 2020-08-20
US11430545B2 (en) 2022-08-30
GB201918389D0 (en) 2020-01-29
JP7343565B2 (ja) 2023-09-12
GB201918335D0 (en) 2020-01-29
US20200005903A1 (en) 2020-01-02
JP2020523705A (ja) 2020-08-06
US20200058377A1 (en) 2020-02-20
AU2018284077A1 (en) 2020-01-02
US11705220B2 (en) 2023-07-18
AU2018282865A1 (en) 2019-12-19
US11367509B2 (en) 2022-06-21
US20180358118A1 (en) 2018-12-13
US20190325993A1 (en) 2019-10-24
CA3065193A1 (en) 2018-12-20
IL270886A (en) 2020-01-30
JP6812580B2 (ja) 2021-01-13
KR20200028388A (ko) 2020-03-16
US10395761B1 (en) 2019-08-27
US20200135302A1 (en) 2020-04-30
GB2601923A8 (en) 2023-03-08
US20240290434A1 (en) 2024-08-29
US20220389512A1 (en) 2022-12-08
CA3065568A1 (en) 2018-12-20
USD891446S1 (en) 2020-07-28
AU2018282759A1 (en) 2020-01-02
DE112018002990T5 (de) 2020-04-02
GB2576680A (en) 2020-02-26
JP7401710B2 (ja) 2023-12-19
US20190179998A9 (en) 2019-06-13

Similar Documents

Publication Publication Date Title
GB2576680B (en) Systems and methods for generating, visualizing and classifying molecular functional profiles
GB2571458B (en) Methods, systems and apparatus for segmenting objects
IL265469B1 (en) Interval tracking using sample tracking chains, systems and methods
GB2567590B (en) Methods, systems and apparatus for segmenting and dimensioning objects
GB2547155B (en) Formation characteristics determination apparatus, methods, and systems
BR112017007052A2 (pt) métodos, aparelhos e sistemas para análise de rede.
ZA201608164B (en) Systems, apparatus, and methods for generating and analyzing resistome profiles
SG11202000871WA (en) Systems, devices, and methods for isotachophoresis
GB2587284B (en) Well ranging apparatus. methods, and systems
GB201714329D0 (en) In-store audio systems, devices, and methods
GB2545947B (en) Dual-energy detection apparatus, system and method
SG10202103868QA (en) Dynamic checkout button apparatuses, methods and systems
GB2549200B (en) Well ranging apparatus, methods and systems
EP3268857A4 (en) Systems, methods, and apparatus for reverse geocoding
GB201621121D0 (en) Railway monitoring systems, apparatus and methods
GB2556198B (en) Imaging apparatuses, systems, and moving imaging objects
GB201714863D0 (en) Draw-down pressure apparatus, systems, and methods
GB201718907D0 (en) Downhole annulus evaluation apparatus, systems, and methods
PL3596443T3 (pl) Urządzenia, systemy i sposoby do analizowania gazu rozpuszczonego
GB201714215D0 (en) Formation property measurement apparatus, methods, and systems
GB201513132D0 (en) Support systems, apparatus and methods
ZA201901084B (en) Classifying apparatus, systems and methods
GB2597875B (en) Methods, systems and apparatus for segmenting and dimensioning objects
GB201803792D0 (en) Distillation systems, apparatus and methods
GB2601940B (en) Methods, systems and apparatus for segmenting and dimensioning objects